litlas
Log inCreate account

Cornelius J. Clancy

Active 1996–2025

116
Papers
23,739
Citations
77
h-index
115
i10-index

Citations

Citations per year for Cornelius J. Clancy1989: 7 citations1990: 1 citations1994: 1 citations1996: 1 citations1997: 1 citations1998: 5 citations1999: 11 citations2000: 13 citations2001: 19 citations2002: 22 citations2003: 18 citations2004: 25 citations2005: 13 citations2006: 15 citations2007: 25 citations2008: 19 citations2009: 22 citations2010: 31 citations2011: 30 citations2012: 45 citations2013: 66 citations2014: 78 citations2015: 80 citations2016: 153 citations2017: 259 citations2018: 234 citations2019: 982 citations2020: 1,127 citations2021: 1,286 citations2022: 1,056 citations2023: 829 citations2024: 1,304 citations2025: 511 citations2026: 12 citations1991–1993: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,068 citing papers, 21.2% of this breakdownChina: 705 citing papers, 7.2% of this breakdownItaly: 612 citing papers, 6.3% of this breakdownUnited Kingdom: 490 citing papers, 5% of this breakdownSpain: 484 citing papers, 5% of this breakdownFrance: 445 citing papers, 4.6% of this breakdownGermany: 356 citing papers, 3.6% of this breakdownAustralia: 309 citing papers, 3.2% of this breakdownNetherlands: 255 citing papers, 2.6% of this breakdownIndia: 245 citing papers, 2.5% of this breakdownCanada: 243 citing papers, 2.5% of this breakdownBrazil: 237 citing papers, 2.4% of this breakdown
0%21.2%Other 33.9%

Institutions

Fields

  • Medicine58.5%
  • Biochemistry, Genetics and Molecular Biology30.3%
  • Immunology and Microbiology7%
  • Agricultural and Biological Sciences0.7%
  • Environmental Science0.7%
  • Health Professions0.6%
  • Other2.2%

Topics

  • Antifungal resistance and susceptibility15.5%
  • Antibiotic Resistance in Bacteria10.6%
  • Fungal Infections and Studies9.9%
  • Antibiotics Pharmacokinetics and Efficacy6.6%
  • Antibiotic Use and Resistance5.7%
  • Bacterial Identification and Susceptibility Testing2.8%
  • Other48.9%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: J. Peter Donnelly, Sharon Chen, Carol A. Kauffman, William J. Steinbach, John W. Baddley, Paul E. Verweij, Cornelius J. Clancy, John R. Wingard, Shawn R. Lockhart, Andreas H. Groll, Tania C. Sorrell, Matteo Bassetti, Hamdi Akan, Barbara D. Alexander, David R. Andes, Élie Azoulay, Ralf Bialek, Robert W. Bradsher, Stéphane Bretagne, Thierry Calandra, Angela M. Caliendo, Elio Castagnola, Mario Cruciani, Manuel Cuenca‐Estrella, Catherine F. Decker, Sujal R. Desai, Brian T. Fisher, Thomas S. Harrison, Claus Peter Heußel, Henrik Elvang Jensen, Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Authors: Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky‐Zeichner, Annette C. Reboli, Mindy G. Schuster, José A. Vázquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel - Clinical Infectious Diseases 2015 cited by 4,037

  3. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

    Authors: Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo, Amy J. Mathers, David van Duin, Cornelius J. Clancy - Clinical Infectious Diseases 2023 cited by 679

  4. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

    Authors: Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo, Amy J. Mathers, David van Duin, Cornelius J. Clancy - Clinical Infectious Diseases 2022 cited by 498

  5. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfections

    Authors: Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo, Amy J. Mathers, David van Duin, Cornelius J. Clancy - Clinical Infectious Diseases 2021 cited by 512

  6. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

    Authors: Ryan K. Shields, Liang Chen, Shaoji Cheng, Kalyan D. Chavda, Ellen G. Press, Avin C. Snyder, Ruchi Pandey, Yohei Doi, Barry N. Kreiswirth, M. Hong Nguyen, Cornelius J. Clancy - Antimicrobial Agents and Chemotherapy 2016 cited by 485

  7. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

    Authors: Ryan K. Shields, M. Hong Nguyen, Liang Chen, Ellen G. Press, Brian A. Potoski, Rachel V Marini, Yohei Doi, Barry N. Kreiswirth, Cornelius J. Clancy - Antimicrobial Agents and Chemotherapy 2017 cited by 487

  8. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

    Authors: Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo, Amy J. Mathers, David van Duin, Cornelius J. Clancy - Clinical Infectious Diseases 2020 cited by 427

  9. Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

    Authors: Cornelius J. Clancy, M. Hong Nguyen - Clinical Infectious Diseases 2013 cited by 684

  10. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    Authors: Paul E. Verweij, Bart Rijnders, Roger J. M. Brüggemann, Élie Azoulay, Matteo Bassetti, Stijn Blot, Thierry Calandra, Cornelius J. Clancy, Oliver A. Cornely, Tom Chiller, Pieter Depuydt, Daniele Roberto Giacobbe, Nico Janssen, Bart Jan Kullberg, Katrien Lagrou, Cornelia Lass‐Flörl, Russell E. Lewis, Wei‐Lun Liu, Olivier Lortholary, Johan Maertens, Ignacio Martín‐Loeches, M. Hong Nguyen, Thomas F. Patterson, Thomas R. Rogers, Jeroen Schouten, Isabel Spriet, Lore Vanderbeke, Joost Wauters, Frank L. van de Veerdonk - Intensive Care Medicine 2020 cited by 454

  11. Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections

    Authors: Ryan K. Shields, M. Hong Nguyen, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, Cornelius J. Clancy - Antimicrobial Agents and Chemotherapy 2018 cited by 286

  12. Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

    Authors: Ryan K. Shields, Brian A. Potoski, Ghady Haidar, Binghua Hao, Yohei Doi, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, Cornelius J. Clancy, M. Hong Nguyen - Clinical Infectious Diseases 2016 cited by 428

  13. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

    Authors: Oliver A. Cornely, Rosanne Sprute, Matteo Bassetti, Wen Chen, Andreas H. Groll, Oliver Kurzai, Cornelia Lass‐Flörl, Luis Ostrosky‐Zeichner, Riina Rautemaa‐Richardson, Gunturu Revathi, Marı́a Elena Santolaya, P Lewis White, Ana Alastruey‐Izquierdo, Maiken Cavling Arendrup, John W. Baddley, Aleksandra Barac, Ronen Ben‐Ami, Adrian Brink, Jan Grothe, Jesús Guinea, Ferry Hagen, Bruno Hochhegger, Martin Hoenigl, Shahid Husain, Kauser Jabeen, Henrik Elvang Jensen, Souha S. Kanj, Philipp Koehler, Thomas Lehrnbecher, Russell E. Lewis, Jacques F. Meis, M. Hong Nguyen, Zoi Dorothea Pana, Peter‐Michael Rath, Ilana Reinhold, Danila Seidel, Takahiro Takazono, Donald C. Vinh, Sean X. Zhang, Javier Afeltra, Abdullah M. S. Al‐Hatmi, Amir Arastehfar, Sevtap Arıkan-Akdağlı, Felix Bongomin, Fabianne Carlesse, Methee Chayakulkeeree, Louis Yi Ann Chai, Leili Chamani‐Tabriz, Tom Chiller, Anuradha Chowdhary, Cornelius J. Clancy, Arnaldo Lopes Colombo, Andrea Cortegiani, Dora Corzo-León, Ľuboš Drgoňa, Anna Dudakova, Joveria Farooqi, Sara Gago, Macit İlkit, Jeffrey D. Jenks, Н Н Климко, Robert Krause, Anil Kumar, Katrien Lagrou, Michail S. Lionakis, B. Lmimouni, Michael K. Mansour, Joseph Meletiadis, Sibylle C. Mellinghoff, Mervyn Mer, Małgorzata Mikulska, Philippe Montravers, Chin Fen Neoh, Volkan Özenci, Livio Pagano, Peter G. Pappas, Thomas F. Patterson, Pedro Puerta‐Alcalde, Laman Rahimli, Sebastian Rahn, Emmanuel Roilides, Coleman Rotstein, Tamara Ruegamer, Raquel Sabino, Jon Salmanton‐García, Ilan S. Schwartz, Esther Segal, Neeraj Sidharthan, Tanu Singhal, János Sinkó, Rajeev Soman, Andrej Spec, Joerg Steinmann, Jannik Stemler, Saad J. Taj‐Aldeen, Alida Fe Talento, George R Thompson, Christina Toebben, Hiram Villanueva‐Lozano, Retno Wahyuningsih and 5 more - The Lancet Infectious Diseases 2025 cited by 296

  14. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Authors: Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky‐Zeichner, Annette C. Reboli, Mindy G. Schuster, José A. Vázquez, Thomas J. Walsh, Theoklis E. Zaoutis, Jack D. Sobel - Clinical Infectious Diseases 2016 cited by 1,283

  15. Diagnosing Invasive Candidiasis

    Authors: Cornelius J. Clancy, M. Hong Nguyen - Journal of Clinical Microbiology 2018 cited by 277

  16. Mutations inblaKPC-3That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases

    Authors: Ghady Haidar, Cornelius J. Clancy, Ryan K. Shields, Binghua Hao, Shaoji Cheng, M. Hong Nguyen - Antimicrobial Agents and Chemotherapy 2017 cited by 192

  17. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance

    Authors: Ghady Haidar, Nathan J Philips, Ryan K. Shields, Daniel J. Snyder, Shaoji Cheng, Brian A. Potoski, Yohei Doi, Binghua Hao, Ellen G. Press, Vaughn S. Cooper, Cornelius J. Clancy, M. Hong Nguyen - Clinical Infectious Diseases 2017 cited by 276

  18. Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections

    Authors: M. Hong Nguyen, Cornelius J. Clancy, A. William Pasculle, Peter G. Pappas, George Alangaden, George A. Pankey, Bryan H. Schmitt, Altaf Rasool, Melvin P. Weinstein, Raymond Widen, Diana R. Hernandez, Donna M. Wolk, Thomas J. Walsh, John R. Perfect, Mollie Wilson, Eleftherios Mylonakis - Annals of Internal Medicine 2019 cited by 117

  19. T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial

    Authors: Eleftherios Mylonakis, Cornelius J. Clancy, Luis Ostrosky‐Zeichner, Kevin W. Garey, George Alangaden, José A. Vázquez, Jeffrey S. Groeger, Marc A. Judson, Yuka-Marie Vinagre, Stephen O. Heard, Fainareti N. Zervou, Ioannis M. Zacharioudakis, Dimitrios P. Kontoyiannis, Peter G. Pappas - Clinical Infectious Diseases 2015 cited by 434

  20. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

    Authors: Paul E. Verweij, Roger J. M. Brüggemann, Élie Azoulay, Matteo Bassetti, Stijn Blot, Jochem B. Buil, Thierry Calandra, Tom Chiller, Cornelius J. Clancy, Oliver A. Cornely, Pieter Depuydt, Philipp Koehler, Katrien Lagrou, Dylan W. de Lange, Cornelia Lass‐Flörl, Russell E. Lewis, Olivier Lortholary, Wei‐Lun Liu, Johan Maertens, M. Hong Nguyen, Thomas F. Patterson, Bart Rijnders, Alejandro Rodríguez, Thomas R. Rogers, Jeroen Schouten, Joost Wauters, Frank L. van de Veerdonk, Ignacio Martín‐Loeches - Intensive Care Medicine 2021 cited by 162

  21. In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam

    Authors: Abigail M Rubio, Ellen G Kline, Chelsea E Jones, Liang Chen, Barry N. Kreiswirth, M. Hong Nguyen, Cornelius J. Clancy, Vaughn S. Cooper, Ghady Haidar, Daria Van Tyne, Ryan K. Shields - Antimicrobial Agents and Chemotherapy 2021 cited by 62

  22. Pharmacokinetic/Pharmacodynamic Profile of Posaconazole

    Authors: Yanjun Li, Ursula Theuretzbacher, Cornelius J. Clancy, M. Hong Nguyen, Hartmut Derendorf - Clinical Pharmacokinetics 2010 cited by 450

  23. Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework

    Authors: Mary Ann Jabra‐Rizk, Eric F. Kong, Christina Tsui, M. Hong Nguyen, Cornelius J. Clancy, Paul L. Fidel, Mairi C. Noverr - Infection and Immunity 2016 cited by 181

  24. Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-abdominal Abscess Model

    Authors: Yanan Zhao, Brendan Prideaux, Yoji Nagasaki, Min Hee Lee, Pei‐Yu Chen, Landry Blanc, Hsinpin Ho, Cornelius J. Clancy, Minh Hong Nguyen, Véronique Dartois, David S. Perlin - Antimicrobial Agents and Chemotherapy 2017 cited by 100